Capacity to Manufacture Drugs and Medical Devices
Canada's Access to Medicines Regime is designed to help
least-developed and developing countries that have little or no
manufacturing capacity in the pharmaceutical sector.
To participate in the Regime, an eligible importing country must declare that
it has insufficient or no pharmaceutical manufacturing capacity in relation to the
specific product it is requesting. It is up to each country to determine for itself
the level of its manufacturing capacity. The Government of Canada will not make an
assessment in this regard. An exception has been made for eligible importing
countries listed on Schedule 2 to Canada's Patent Act. These countries are deemed
to have insufficient manufacturing capacity in the pharmaceutical sector.
Countries that participate in the Regime can use the contacts they
develop with Canadian pharmaceutical companies to help them build their
manufacturing capacity over the longer term.
For information on participating in Canada's Access to Medicines Regime,
proceed to Requirements for Importing
Countries.
|